Rosetta plans to use the proceeds for general corporate purposes and to support the development of its microRNA-based diagnostic pipeline. Read More
01/20/10 | Science Center Companies
Rosetta plans to use the proceeds for general corporate purposes and to support the development of its microRNA-based diagnostic pipeline. Read More